Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$12.2M Buy
168,767
+5,155
+3% +$347K 0.34% 93
2017
Q1
$10.7M Buy
163,612
+10,003
+7% +$629K 0.32% 94
2016
Q4
$9.62M Buy
153,609
+29,454
+24% +$1.8M 0.3% 101
2016
Q3
$7.83M Buy
124,155
+8,977
+8% +$581K 0.24% 99
2016
Q2
$7.13M Sell
115,178
-251
-0.2% -$15.3K 0.24% 104
2016
Q1
$6.59M Sell
115,429
-17,616
-13% -$982K 0.22% 109
2015
Q4
$7.88M Buy
133,045
+9,700
+8% +$559K 0.27% 84
2015
Q3
$6.71M Buy
123,345
+8,173
+7% +$532K 0.21% 111
2015
Q2
$7.74M Buy
115,172
+46,632
+68% +$3.04M 0.24% 103
2015
Q1
$4.01M Sell
68,540
-2,327
-3% -$141K 0.12% 117
2014
Q4
$4.64M Buy
70,867
+5,966
+9% +$376K 0.14% 112
2014
Q3
$3.75M Buy
64,901
+3,550
+6% +$197K 0.03% 121
2014
Q2
$3.46M Buy
61,351
+5,740
+10% +$301K 0.11% 118
2014
Q1
$2.86M Buy
55,611
+4,518
+9% +$228K 0.1% 118
2013
Q4
$2.7M Buy
51,093
+10,015
+24% +$492K 0.09% 126
2013
Q3
$1.84M Buy
41,078
+2,526
+7% +$112K 0.07% 182
2013
Q2
$1.59M Buy
+38,552
New +$1.69M 0.06% 185

Other funds holding ABBV

Delta Lloyd's ABBV Position: Q2 2017 in Review

Delta Lloyd increased its AbbVie (ABBV) stake by 3.2% in Q2 2017, buying an estimated $347K and bringing the position to 168,767 shares worth $12.2M. The position accounts for 0.34% of the portfolio, ranked #93.

Delta Lloyd first reported a position in ABBV in Q2 2013 and has held it in 17 quarters since. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.

  • Delta Lloyd held 168,767 shares of AbbVie worth $12.2M as of Q2 2017.
  • Delta Lloyd bought 5,155 AbbVie shares in Q2 2017, an estimated $347K.
  • AbbVie made up 0.34% of Delta Lloyd's portfolio in Q2 2017, its #93 holding.
  • Delta Lloyd first reported a position in AbbVie in Q2 2013 and has held it in 17 quarters since.
  • 1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.

Based on Delta Lloyd's 13F filing for Q2 2017, filed 9 Aug 2017.